Achilles Therapeutics’ $175.5 Million Initial Public Offering

Latham & Watkins LLP represented the underwriters in the offering while Goodwin Procter LLP advised Achilles Therapeutics plc. Achilles Therapeutics plc, a clinical-stage biopharmaceutical company developing…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here